Skip to main content
SpringerLink
Log in

HRT and the Secondary Prevention of Coronary Heart Disease

  • Chapter
Women’s Health and Menopause

Part of the book series: Medical Science Symposia Series ((MSSS,volume 11))

  • 107 Accesses

Abstract

In the past, the major indication for hormone replacement therapy (HRT) was the relief of acute menopausal symptoms, but more recently it is being used for the prevention and treatment of osteoporosis [1]. However, the major indication for its use in the future may be the prevention and treatment of cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stevenson JC, Crook D, Godsland IF. Cardiovascular and skeletal effects of hormone replacement therapy. In: Seymour CA, Weetman AP, editors. Horizons in medicine No. 5. London: Blackwell Scientific Publications, 1994: 92–101.

    Google Scholar 

  2. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med 1978;89:157–61.

    PubMed  CAS  Google Scholar 

  3. Spencer CP, Cooper AJ, Stevenson JC. Clinical trials in progress with hormone replacement therapy. Exp Opin Invest Drugs 1996;5:739–49.

    Article  CAS  Google Scholar 

  4. Hunt K, Vessey M, McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: An updated analysis. Br J Obstet Gynaecol 1990;97:1080–86.

    Article  PubMed  CAS  Google Scholar 

  5. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease. N Eng J Med 1991;325:756–62.

    Article  CAS  Google Scholar 

  6. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 1991;151:75–78.

    Article  PubMed  CAS  Google Scholar 

  7. Finucane FF, Madans JII, Bush TL, et al. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med 1993;153:73–79.

    Article  PubMed  CAS  Google Scholar 

  8. Falkeborn M, Persson I, Adami H-O, et al. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol 1992;99:821–28.

    Article  PubMed  CAS  Google Scholar 

  9. Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453–61.

    Article  PubMed  CAS  Google Scholar 

  10. Gruchow HW, Anderson AJ, Barboriak JJ, et al. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954–63.

    Article  PubMed  CAS  Google Scholar 

  11. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992;69:176–8.

    Article  PubMed  CAS  Google Scholar 

  12. Sullivan JM, Zwang RV, Hughes JP, et al. Estrogen replacement therapy and coronary artery disease. Arch Intern Med 1990;150:2557–62.

    Article  PubMed  CAS  Google Scholar 

  13. O’Brien JE, Peterson ED, Keeler GP, et al. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1996;28:1111–8.

    Article  PubMed  Google Scholar 

  14. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993;98:83–90.

    Article  PubMed  CAS  Google Scholar 

  15. Crook D, Cust MP, Gangar KF, et al. Comparison of transdermal and oral estrogen/progestin hormone replacement therapy: effects on serum lipids and lipoproteins. Am J Obstet Gynecol 1992;166:950–55.

    PubMed  CAS  Google Scholar 

  16. Westerveld HT, Kock LAW, van Rijn JM, Erkelens DW, de Bruin TWA. 17 β-estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 1995;80:249–53.

    Article  PubMed  CAS  Google Scholar 

  17. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269–70.

    Article  PubMed  CAS  Google Scholar 

  18. Godsland IF, Stevenson JC. Insulin resistance: Syndrome or tendency? Lancet 1995;346:100–3.

    Article  PubMed  CAS  Google Scholar 

  19. Stevenson JC. The metabolic and cardiovascular consequences of HRT. Br J Clin Pract 1995;49:87–90

    PubMed  CAS  Google Scholar 

  20. Collins P, Rosano GMC, Sarrel PM, et al. 17 β-estradiol attentuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995;92:24–30.

    Article  PubMed  CAS  Google Scholar 

  21. Jiang C, Poole-Wilson PA, Sarrel PM, et al. Effect of 17 β-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992;106:739–45.

    Article  PubMed  CAS  Google Scholar 

  22. Proudler AJ, Ahmed AIH, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and scrum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995;346:89–90.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. John C. Stevenson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Pharmacological Sciences, University of Milan, Milan, Italy

    R. Paoletti

  2. Department of Obstetrics and Gynecology, University of Milan, Milan, Italy

    P. G. Crosignani

  3. Department of Obstetrics and Gynaecology, University Hospital Vrije Universiteit, Amsterdam, The Netherlands

    P. Kenemans

  4. Department of Obstetrics and Gynecology, Lund University Hospital, Lund, Sweden

    G. Samsioe

  5. Institute of Pharmacological Sciences, University of Milan, Milan, Italy

    M. R. Soma

  6. Giovanni Lorenzini Medical Foundation, Houston, Texas, USA

    A. S. Jackson (Managing Editor) (Managing Editor)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Stevenson, J.C. (1997). HRT and the Secondary Prevention of Coronary Heart Disease. In: Paoletti, R., Crosignani, P.G., Kenemans, P., Samsioe, G., Soma, M.R., Jackson, A.S. (eds) Women’s Health and Menopause. Medical Science Symposia Series, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5560-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5560-1_19

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6343-2

  • Online ISBN: 978-94-011-5560-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation